GB0520316D0 - Treatment of neurodegenerative and psychiatric diseases - Google Patents

Treatment of neurodegenerative and psychiatric diseases

Info

Publication number
GB0520316D0
GB0520316D0 GB0520316A GB0520316A GB0520316D0 GB 0520316 D0 GB0520316 D0 GB 0520316D0 GB 0520316 A GB0520316 A GB 0520316A GB 0520316 A GB0520316 A GB 0520316A GB 0520316 D0 GB0520316 D0 GB 0520316D0
Authority
GB
United Kingdom
Prior art keywords
neurodegenerative
treatment
psychiatric diseases
psychiatric
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0520316A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GB0520316A priority Critical patent/GB0520316D0/en
Publication of GB0520316D0 publication Critical patent/GB0520316D0/en
Priority to JP2008534088A priority patent/JP2009511462A/en
Priority to PCT/GB2006/050317 priority patent/WO2007039773A1/en
Priority to CA002624795A priority patent/CA2624795A1/en
Priority to US11/992,913 priority patent/US20090306169A1/en
Priority to AU2006298563A priority patent/AU2006298563A1/en
Priority to EP06779660A priority patent/EP1942885A1/en
Ceased legal-status Critical Current

Links

GB0520316A 2005-10-06 2005-10-06 Treatment of neurodegenerative and psychiatric diseases Ceased GB0520316D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB0520316A GB0520316D0 (en) 2005-10-06 2005-10-06 Treatment of neurodegenerative and psychiatric diseases
JP2008534088A JP2009511462A (en) 2005-10-06 2006-10-05 Use of condensed pyrrole carboxylic acids to treat neurodegeneration and psychiatric disorders as D-amino acid oxidase inhibitors
PCT/GB2006/050317 WO2007039773A1 (en) 2005-10-06 2006-10-05 Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors
CA002624795A CA2624795A1 (en) 2005-10-06 2006-10-05 Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors
US11/992,913 US20090306169A1 (en) 2005-10-06 2006-10-05 Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors
AU2006298563A AU2006298563A1 (en) 2005-10-06 2006-10-05 Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as D-amino acid oxidase inhibitors
EP06779660A EP1942885A1 (en) 2005-10-06 2006-10-05 Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0520316A GB0520316D0 (en) 2005-10-06 2005-10-06 Treatment of neurodegenerative and psychiatric diseases

Publications (1)

Publication Number Publication Date
GB0520316D0 true GB0520316D0 (en) 2005-11-16

Family

ID=35429902

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0520316A Ceased GB0520316D0 (en) 2005-10-06 2005-10-06 Treatment of neurodegenerative and psychiatric diseases

Country Status (1)

Country Link
GB (1) GB0520316D0 (en)

Similar Documents

Publication Publication Date Title
HRP20150175T1 (en) Means and methods for the treatment of tumorous diseases
EP1968607A4 (en) Treatment of cancer and other diseases
EP1861126A4 (en) Treatment of protein degradation disorders
EP2004204A4 (en) Treatment of neurodegenerative diseases
ZA200800907B (en) Treatment of cancer
GB0603181D0 (en) Treatment of neurodegenerative and psychiatric diseases
GB2415378B (en) Treatment of neurodegenerative conditions
EP1957064A4 (en) Treatment of qt interval prolongation and diseases associated therewith
GB2422373B (en) Treatment of neurodegenerative conditions
EP1962869A4 (en) Treatment of respiratory diseases
GB0610183D0 (en) Treatment of neurodegenerative diseases
GB0523961D0 (en) The treatment of ophthalmic diseases
ZA200806095B (en) Means and methods for the treatment of tumorous diseases
ZA200805108B (en) Treatment of neurodegenerative disorders
ZA200802270B (en) Treatment of neurodegenerative disorders
GB0300783D0 (en) Treatment of neurodegenerative conditions
EP1951282A4 (en) Treatment of hypersensitivity
GB0520067D0 (en) Treatment of cancer
GB0519274D0 (en) The treatment of neurodegenerative diseases
GB0523964D0 (en) The treatment of ophthalmic diseases
GB0520316D0 (en) Treatment of neurodegenerative and psychiatric diseases
EP1846013A4 (en) Treatment of skin diseases
GB0602783D0 (en) Treatment Of Neurodegenerative And Psychiatric Diseases
GB0410846D0 (en) Treatment of neurodegenerative conditions
GB2442164B (en) Treatment of neurodegenerative conditions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)